Search clinical trials for: Inactivated poliovirus vaccine

Total 10077 results

Centre Hospitalier Universitaire de Nice

Completed

Cholera Toxin B Subunit (CTB) Administered by Mucosal Way in Healthy Adult Volunteer

Infection

France
National Institute of Allergy and Infectious Diseases...

Terminated

Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, Mali

Malaria

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults

Healthy

United States
Immtech Pharmaceuticals, Inc
Bill and Melinda Gates Foundation

Completed

Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

African Trypanosomiasis

Congo
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months

Influenza

Singapore
African Malaria Network Trust

Unknown

Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years

Malaria

Gabon
PowderMed

Completed

Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection

Chronic Hepatitis B

Thailand, Hong Kong, Singapore, Taiwan
PowderMed

Completed

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

HSV-2

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

Influenza

United States
Japan Adult Leukemia Study Group

Unknown

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Lymphoblastic Leukemia, Acute

Japan
AlphaVax, Inc.

Completed

A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV) (CMV)

Cytomegalovirus Infections

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine

Virus Diseases | Influenza

United States
AlphaVax, Inc.

Completed

A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza

Influenza

United States
Cell Genesys

Terminated

GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer

United States, France, Belgium, Canada, United Kingdom, Sweden, Netherlands, Germany
St George's, University of London
Novartis Vaccines; Statens Serum Institut; European Union

Terminated

A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) (TMUVA-01)

Tuberculosis

United Kingdom
University Hospital Inselspital, Berne
Merck Sharp & Dohme LLC; Boehringer Ingelheim; Abbott; Solvay Pharmaceuticals

Completed

Influenza Vaccination in Immunocompromized Patients

Immunosuppression

Switzerland
Agenus Inc.

Completed

Trial Evaluating Safety, Tolerability and Immune Response of AG-707

Genital Herpes

United States
Solvay Pharmaceuticals

Terminated

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Healthy Subjects

Finland, Germany
Mahidol University
Chiron company: Clinical Research and Medical Affairs

Completed

Rabies Immunization Concomitant With JEV in Children

Rabies
Bandim Health Project
Medical Research Council Unit, The Gambia; International Cooperation with Developing... and other collaborators

Terminated

Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine

Malaria

Guinea-Bissau
University of Melbourne
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Pneumococcal Vaccination of Fiji Infants

Pneumococcal Infections

Fiji
Universitaire Ziekenhuizen KU Leuven

Completed

Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients

Hemodialysis | Renal Transplantation

Belgium
GlaxoSmithKline

Completed

Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population

Hepatitis A
GlaxoSmithKline

Completed

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Prophylactic Pneumococcal Diseases

Belgium
GlaxoSmithKline

Completed

Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes

Measles | Rubella | Mumps | Varicella

Germany
Hadassah Medical Organization

Unknown

Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem

HIV Infections | Influenza | Acquired Immune Deficiency Syndrome

Israel
University of Witwatersrand, South Africa

Completed

Efficacy of Influenza Vaccine in HIV Infected Adults

HIV Infections | HIV | Influenza | Vaccination

South Africa
UConn Health

Terminated

Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70

Breast Neoplasms

United States
University of Bamako
UNICEF

Completed

Intermittent Preventive Treatment in Infant in Mali

Malaria

Mali
Cell Genesys

Unknown

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Carcinoma, Transitional Cell | Bladder Neoplasms

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People

HIV Infections | Hepatitis B

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Unknown

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Unknown

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

HIV Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Investigating Administration of Prevenar for Post-Marketing Surveillance

Pneumococcal Infections

Korea, Republic of
Cell Genesys

Terminated

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Prostate Cancer

United States, France, United Kingdom, Italy, Germany, Netherlands, Canada, Poland, Sweden, Belgium
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

One Year Study to Evaluate Three Different Adjuvanted Doses of the Recombinant Plague Vaccine (rF1 and rV Antigens)

Plague

United States, United Kingdom
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Bacillus Anthracis (Anthrax)

United States
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase II Study of Range and Schedule of rPA Doses

Prevention of Bacillus Anthracis (Anthrax) Infection

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

HIV Infections

United States
MedImmune LLC

Completed

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Healthy

United States
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Hepatitis B

Belgium, Czech Republic, Hungary
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

Hepatitis B

Belgium, Czech Republic, Hungary
Henogen
GlaxoSmithKline

Completed

Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

Hepatitis B

Belgium, Czech Republic, Hungary
Cosmo Bioscience

Completed

Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

Prostatic Neoplasms

United States
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; Aga Khan University; University of Western Ontario...

Completed

Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood

Typhoid | Paratyphoid Fever

Pakistan
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; University of Western Ontario, Canada; National...

Completed

Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever

Typhoid | Paratyphoid Fever

India
Henogen

Completed

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

Hepatitis B

Czech Republic
GlaxoSmithKline
Corixa Corporation

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults

Tuberculosis (TB)

United States

3

Subscribe